Showing results (671-680 of 863) with videos related to
Sort By:
Pageof 87
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagusJ S Waters, D Tait, D Cunningham, et al.British Journal of Cancer|August 11, 2005
Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecanG Chong, J L B Dickson, D Cunningham, et al.Lancet (London, England)|August 24, 1991
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapyA L Jones, A S Hill, M Soukop, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
High-dose melphalan for multiple myeloma: long-term follow-up dataD Cunningham, L Paz-Ares, M E Gore, et al.Clinical Radiology|February 13, 2021
Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shiftS Zafar, R K Sharma, J Cunningham, et al.Hematological Oncology|November 1, 1990
Decrease in clonogenic tumour cells in bone marrow aspirates from multiple myeloma patients due to the incorporation of cyclophosphamide into treatment with vincristine, adriamycin and methyl prednisoloneJ B Bell, B C Millar, A Montes-Borinaga, et al.Clinical Radiology|September 28, 2021
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): a good practice guide, pictorial review, and new perspectivesA S Mehdi, G Bitar, R K Sharma, et al.Biorxiv : the Preprint Server for Biology|July 10, 2026
Neprilysin mediated cleavage of phospholamban dysregulates SERCA in heart failureJacob D Cunningham, Taylor A Phillips, Alexis R Mazzenga, et al.Blood|May 9, 2001
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBOP N Mainwaring, D Cunningham, W Gregory, et al.Lancet (London, England)|March 19, 1994
Placebo-controlled phase III trial of lenograstim in bone-marrow transplantationC Gisselbrecht, H G Prentice, A Bacigalupo, et al.Pageof 87